资讯库
更紧凑的生命科学资讯库。
先搜索，再按来源或主题继续收窄。
Lineage Cell宣布达成与罗氏协议中OpRegen的首个研发里程碑——TipRanks
Lineage Cell says first OpRegen development milestone under Roche pact achieved TipRanks
KaliVir Immunotherapeutics宣布与罗氏达成临床试验合作与供应协议，共同评估VET3-TGI联合阿特珠单抗（Tecentriq®）治疗晚期实体瘤的效果——雅虎财经报道
KaliVir Immunotherapeutics Announces Clinical Trial Collaboration and Supply Agreement with Roche to Evaluate VET3-TGI in Combination with Atezolizumab (Tecentriq®) in...
Freenome与罗氏达成独家协议，扩大技术合作并在美国以外地区开发和商业化癌症筛查检测 - PR Newswire
Freenome Announces Exclusive Agreement with Roche to Expand Technology Collaboration and Develop and Commercialize Cancer Screening Tests Outside the U.S. PR Newswire
新型实验性药物或将改变癌症患者护理方式——独立报
New experimental drug could transform care for cancer patients The Independent
罗氏制药管线进展与股价飙升17%后，是否该重新评估其投资时机？ - simplywall.st
Is Now the Moment to Reassess Roche After Its Drug Pipeline Developments and 17% Stock Jump? simplywall.st
罗氏实验性多发性硬化药物在两项关键试验中一项达到主要目标——路透社
Roche's experimental MS drug hits main goal in one of two key trials Reuters
罗氏竞争对手因多发性硬化症治疗“史无前例”结果股价暴跌——投资者商业日报
Roche Rival Plunges On 'Unprecedented' Results In MS Treatment Investor's Business Daily